Compliant CBDa Concentrates & FOrmulation ingredients

NeXtraction Cannabinoid Concentrate is a total THC compliant, broad spectrum (non-detectable THC) ingredient comprised of naturally prevalent  phytocannabinoids and phytocompounds in acidic form.

Each batch duplicates the natural, comprehensive phytocannabinoid and phytocompound expression of the specific genetic variant of the cultivated hemp.

Batch profiles typically range from 70%-to-98% in total  acidic cannabinoid potency, in addition to flavonoids, terpenes and omegas.

NeXtraction Cannabinoid Concentrate may be used as a single, base ingredient from which to isolate both acidic and neutral cannabinoids, as desired. 

Pre-screening for ideal soil composition, coupled with strong genetic selection, cannot be underestimated in providing a clean, vibrant, base ingredient from which to formulate product. 

Farming partners are selected after conducting extensive due diligence, including on-sight inspection of premises and random biomass sampling for pesticide and heavy metal presence. 

In addition to in-house, lab research, NeXtraction collaborates with some of the most acclaimed academic and private scientific research organizations in the U.S., and EU, giving customer-partners access to great depth in current, collaborative knowledge when conducting research and formulary development.

NeXtraction Cannabinoid Concentrate upholds the holistic integrity of The Entourage Effect, whereby the complementary interaction of cannabinoids, flavonoids, terpenes, omegas and other important, individual phytocompounds naturally present in hemp is purported to provide optimal, therapeutic efficacy.  In principle, The Entourage Effect is the realized, biological magnification which comes from the combined formation of these component compounds in their naturally unified, unadulterated state. 

NeXtraction works in partnership with customer-partners to optimize cannabinoid ingredient profiles desired most for research and formulary development. We begin by collaborating with research organizations specializing in genotype mapping, where we are then able to initiate the supply chain cycle by helping farmers select high quality strains desired most by customer-partners for production.